{
  "kind": "all",
  "value": "all",
  "collectionKey": "slides:all:all:all-document-kinds:all-producers:all-orientations",
  "filters": {
    "documentKinds": [],
    "sourceTypes": [],
    "orientations": []
  },
  "total": 319975,
  "page": 7321,
  "pageSize": 30,
  "pageCount": 10666,
  "rows": [
    {
      "docId": "019de076-2351-76a2-9dc5-1c75bf1dd158",
      "docSlug": "905d9ceaf5cb608feb86b583a8401e54",
      "documentTitle": "AstraZeneca | Results Presentation Deck | 45 slides",
      "authorId": "astrazeneca",
      "authorName": "AstraZeneca",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 16,
      "slideType": "key_messages",
      "function": "summarize",
      "notes": "The slide uses a dual-column layout to contrast a strategic roadmap for Tagrisso with a competitive performance chart for Calquence.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-2351-76a2-9dc5-1c75bf1dd158/16",
      "deckHref": "/decks/019de076-2351-76a2-9dc5-1c75bf1dd158",
      "deckAnchorHref": "/decks/019de076-2351-76a2-9dc5-1c75bf1dd158#slide-16",
      "loopMatches": [
        {
          "to": 20,
          "from": 5,
          "name": "Logic Chain",
          "slug": "01-logic-chain",
          "bestFor": "Skeptical audiences, controversial recommendations, rigorous analysis",
          "matchId": "4272c71f-edd6-48f7-a353-789a42575177",
          "evidence": "The document walks through a logical chain of financial performance, portfolio evolution, and R&D highlights",
          "position": 0,
          "objective": "How AstraZeneca's diversified portfolio drives growth",
          "structure": "Premise 1 (Accepted truth) -> Premise 2 (Observed fact) -> Therefore... (Inevitable conclusion)",
          "confidence": 0.7,
          "description": "Build an airtight chain of logic where each premise leads inevitably to the conclusion"
        },
        {
          "to": 20,
          "from": 13,
          "name": "Cost Of Inaction",
          "slug": "27-cost-of-inaction",
          "bestFor": "Urgent budget requests, compliance, risk mitigation",
          "matchId": "f01e337f-a074-4bb0-a0a6-8afab8af6ed6",
          "evidence": "The document highlights the potential consequences of inaction in not leveraging technology for better patient outcomes",
          "position": 1,
          "objective": "The importance of harnessing technology to deliver better patient outcomes",
          "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
          "confidence": 0.6,
          "description": "Quantify what happens if the audience does nothing"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 20,
          "from": 15,
          "beatId": "88166dd9-a0d1-4ffb-ac51-e141aedff5d2",
          "arcName": "Monroe's Motivated Sequence",
          "arcSlug": "monroes-sequence",
          "beatName": "Satisfaction",
          "beatSlug": "monroes-sequence-satisfaction",
          "evidence": "Key takeaways and highlights from Oncology and BioPharmaceuticals",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Turn",
          "parentBeatSlug": "turn"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-2351-76a2-9dc5-1c75bf1dd158",
      "docSlug": "905d9ceaf5cb608feb86b583a8401e54",
      "documentTitle": "AstraZeneca | Results Presentation Deck | 45 slides",
      "authorId": "astrazeneca",
      "authorName": "AstraZeneca",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 17,
      "slideType": "key_messages",
      "function": "summarize",
      "notes": "Includes medical imaging and bar charts for clinical trial outcomes.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-2351-76a2-9dc5-1c75bf1dd158/17",
      "deckHref": "/decks/019de076-2351-76a2-9dc5-1c75bf1dd158",
      "deckAnchorHref": "/decks/019de076-2351-76a2-9dc5-1c75bf1dd158#slide-17",
      "loopMatches": [
        {
          "to": 20,
          "from": 5,
          "name": "Logic Chain",
          "slug": "01-logic-chain",
          "bestFor": "Skeptical audiences, controversial recommendations, rigorous analysis",
          "matchId": "4272c71f-edd6-48f7-a353-789a42575177",
          "evidence": "The document walks through a logical chain of financial performance, portfolio evolution, and R&D highlights",
          "position": 0,
          "objective": "How AstraZeneca's diversified portfolio drives growth",
          "structure": "Premise 1 (Accepted truth) -> Premise 2 (Observed fact) -> Therefore... (Inevitable conclusion)",
          "confidence": 0.7,
          "description": "Build an airtight chain of logic where each premise leads inevitably to the conclusion"
        },
        {
          "to": 20,
          "from": 13,
          "name": "Cost Of Inaction",
          "slug": "27-cost-of-inaction",
          "bestFor": "Urgent budget requests, compliance, risk mitigation",
          "matchId": "f01e337f-a074-4bb0-a0a6-8afab8af6ed6",
          "evidence": "The document highlights the potential consequences of inaction in not leveraging technology for better patient outcomes",
          "position": 1,
          "objective": "The importance of harnessing technology to deliver better patient outcomes",
          "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
          "confidence": 0.6,
          "description": "Quantify what happens if the audience does nothing"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 20,
          "from": 15,
          "beatId": "88166dd9-a0d1-4ffb-ac51-e141aedff5d2",
          "arcName": "Monroe's Motivated Sequence",
          "arcSlug": "monroes-sequence",
          "beatName": "Satisfaction",
          "beatSlug": "monroes-sequence-satisfaction",
          "evidence": "Key takeaways and highlights from Oncology and BioPharmaceuticals",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Turn",
          "parentBeatSlug": "turn"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-2351-76a2-9dc5-1c75bf1dd158",
      "docSlug": "905d9ceaf5cb608feb86b583a8401e54",
      "documentTitle": "AstraZeneca | Results Presentation Deck | 45 slides",
      "authorId": "astrazeneca",
      "authorName": "AstraZeneca",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 18,
      "slideType": "key_messages",
      "function": "analyze_data",
      "notes": "Includes waterfall plots for two patient cohorts and a trial design schematic.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-2351-76a2-9dc5-1c75bf1dd158/18",
      "deckHref": "/decks/019de076-2351-76a2-9dc5-1c75bf1dd158",
      "deckAnchorHref": "/decks/019de076-2351-76a2-9dc5-1c75bf1dd158#slide-18",
      "loopMatches": [
        {
          "to": 20,
          "from": 5,
          "name": "Logic Chain",
          "slug": "01-logic-chain",
          "bestFor": "Skeptical audiences, controversial recommendations, rigorous analysis",
          "matchId": "4272c71f-edd6-48f7-a353-789a42575177",
          "evidence": "The document walks through a logical chain of financial performance, portfolio evolution, and R&D highlights",
          "position": 0,
          "objective": "How AstraZeneca's diversified portfolio drives growth",
          "structure": "Premise 1 (Accepted truth) -> Premise 2 (Observed fact) -> Therefore... (Inevitable conclusion)",
          "confidence": 0.7,
          "description": "Build an airtight chain of logic where each premise leads inevitably to the conclusion"
        },
        {
          "to": 20,
          "from": 13,
          "name": "Cost Of Inaction",
          "slug": "27-cost-of-inaction",
          "bestFor": "Urgent budget requests, compliance, risk mitigation",
          "matchId": "f01e337f-a074-4bb0-a0a6-8afab8af6ed6",
          "evidence": "The document highlights the potential consequences of inaction in not leveraging technology for better patient outcomes",
          "position": 1,
          "objective": "The importance of harnessing technology to deliver better patient outcomes",
          "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
          "confidence": 0.6,
          "description": "Quantify what happens if the audience does nothing"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 20,
          "from": 15,
          "beatId": "88166dd9-a0d1-4ffb-ac51-e141aedff5d2",
          "arcName": "Monroe's Motivated Sequence",
          "arcSlug": "monroes-sequence",
          "beatName": "Satisfaction",
          "beatSlug": "monroes-sequence-satisfaction",
          "evidence": "Key takeaways and highlights from Oncology and BioPharmaceuticals",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Turn",
          "parentBeatSlug": "turn"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-2351-76a2-9dc5-1c75bf1dd158",
      "docSlug": "905d9ceaf5cb608feb86b583a8401e54",
      "documentTitle": "AstraZeneca | Results Presentation Deck | 45 slides",
      "authorId": "astrazeneca",
      "authorName": "AstraZeneca",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 19,
      "slideType": "key_messages",
      "function": "summarize",
      "notes": "The slide uses a pipeline table and a waterfall chart to demonstrate clinical progress.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-2351-76a2-9dc5-1c75bf1dd158/19",
      "deckHref": "/decks/019de076-2351-76a2-9dc5-1c75bf1dd158",
      "deckAnchorHref": "/decks/019de076-2351-76a2-9dc5-1c75bf1dd158#slide-19",
      "loopMatches": [
        {
          "to": 20,
          "from": 5,
          "name": "Logic Chain",
          "slug": "01-logic-chain",
          "bestFor": "Skeptical audiences, controversial recommendations, rigorous analysis",
          "matchId": "4272c71f-edd6-48f7-a353-789a42575177",
          "evidence": "The document walks through a logical chain of financial performance, portfolio evolution, and R&D highlights",
          "position": 0,
          "objective": "How AstraZeneca's diversified portfolio drives growth",
          "structure": "Premise 1 (Accepted truth) -> Premise 2 (Observed fact) -> Therefore... (Inevitable conclusion)",
          "confidence": 0.7,
          "description": "Build an airtight chain of logic where each premise leads inevitably to the conclusion"
        },
        {
          "to": 20,
          "from": 13,
          "name": "Cost Of Inaction",
          "slug": "27-cost-of-inaction",
          "bestFor": "Urgent budget requests, compliance, risk mitigation",
          "matchId": "f01e337f-a074-4bb0-a0a6-8afab8af6ed6",
          "evidence": "The document highlights the potential consequences of inaction in not leveraging technology for better patient outcomes",
          "position": 1,
          "objective": "The importance of harnessing technology to deliver better patient outcomes",
          "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
          "confidence": 0.6,
          "description": "Quantify what happens if the audience does nothing"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 20,
          "from": 15,
          "beatId": "88166dd9-a0d1-4ffb-ac51-e141aedff5d2",
          "arcName": "Monroe's Motivated Sequence",
          "arcSlug": "monroes-sequence",
          "beatName": "Satisfaction",
          "beatSlug": "monroes-sequence-satisfaction",
          "evidence": "Key takeaways and highlights from Oncology and BioPharmaceuticals",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Turn",
          "parentBeatSlug": "turn"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-2351-76a2-9dc5-1c75bf1dd158",
      "docSlug": "905d9ceaf5cb608feb86b583a8401e54",
      "documentTitle": "AstraZeneca | Results Presentation Deck | 45 slides",
      "authorId": "astrazeneca",
      "authorName": "AstraZeneca",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 20,
      "slideType": "key_messages",
      "function": "present_solution",
      "notes": "Includes a navigation bar at the top indicating this is part of a larger presentation.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-2351-76a2-9dc5-1c75bf1dd158/20",
      "deckHref": "/decks/019de076-2351-76a2-9dc5-1c75bf1dd158",
      "deckAnchorHref": "/decks/019de076-2351-76a2-9dc5-1c75bf1dd158#slide-20",
      "loopMatches": [
        {
          "to": 20,
          "from": 5,
          "name": "Logic Chain",
          "slug": "01-logic-chain",
          "bestFor": "Skeptical audiences, controversial recommendations, rigorous analysis",
          "matchId": "4272c71f-edd6-48f7-a353-789a42575177",
          "evidence": "The document walks through a logical chain of financial performance, portfolio evolution, and R&D highlights",
          "position": 0,
          "objective": "How AstraZeneca's diversified portfolio drives growth",
          "structure": "Premise 1 (Accepted truth) -> Premise 2 (Observed fact) -> Therefore... (Inevitable conclusion)",
          "confidence": 0.7,
          "description": "Build an airtight chain of logic where each premise leads inevitably to the conclusion"
        },
        {
          "to": 20,
          "from": 13,
          "name": "Cost Of Inaction",
          "slug": "27-cost-of-inaction",
          "bestFor": "Urgent budget requests, compliance, risk mitigation",
          "matchId": "f01e337f-a074-4bb0-a0a6-8afab8af6ed6",
          "evidence": "The document highlights the potential consequences of inaction in not leveraging technology for better patient outcomes",
          "position": 1,
          "objective": "The importance of harnessing technology to deliver better patient outcomes",
          "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
          "confidence": 0.6,
          "description": "Quantify what happens if the audience does nothing"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 20,
          "from": 15,
          "beatId": "88166dd9-a0d1-4ffb-ac51-e141aedff5d2",
          "arcName": "Monroe's Motivated Sequence",
          "arcSlug": "monroes-sequence",
          "beatName": "Satisfaction",
          "beatSlug": "monroes-sequence-satisfaction",
          "evidence": "Key takeaways and highlights from Oncology and BioPharmaceuticals",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Turn",
          "parentBeatSlug": "turn"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-2351-76a2-9dc5-1c75bf1dd158",
      "docSlug": "905d9ceaf5cb608feb86b583a8401e54",
      "documentTitle": "AstraZeneca | Results Presentation Deck | 45 slides",
      "authorId": "astrazeneca",
      "authorName": "AstraZeneca",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 21,
      "slideType": "cover",
      "function": "front_matter",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-2351-76a2-9dc5-1c75bf1dd158/21",
      "deckHref": "/decks/019de076-2351-76a2-9dc5-1c75bf1dd158",
      "deckAnchorHref": "/decks/019de076-2351-76a2-9dc5-1c75bf1dd158#slide-21",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-2351-76a2-9dc5-1c75bf1dd158",
      "docSlug": "905d9ceaf5cb608feb86b583a8401e54",
      "documentTitle": "AstraZeneca | Results Presentation Deck | 45 slides",
      "authorId": "astrazeneca",
      "authorName": "AstraZeneca",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 22,
      "slideType": "kpi_overview",
      "function": "analyze_data",
      "notes": "Slide includes a navigation bar at the top indicating current section is BioPharmaceuticals.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-2351-76a2-9dc5-1c75bf1dd158/22",
      "deckHref": "/decks/019de076-2351-76a2-9dc5-1c75bf1dd158",
      "deckAnchorHref": "/decks/019de076-2351-76a2-9dc5-1c75bf1dd158#slide-22",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-2351-76a2-9dc5-1c75bf1dd158",
      "docSlug": "905d9ceaf5cb608feb86b583a8401e54",
      "documentTitle": "AstraZeneca | Results Presentation Deck | 45 slides",
      "authorId": "astrazeneca",
      "authorName": "AstraZeneca",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 23,
      "slideType": "key_takeaways",
      "function": "summarize",
      "notes": "The slide uses a three-column layout to present distinct performance metrics for three key product areas.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-2351-76a2-9dc5-1c75bf1dd158/23",
      "deckHref": "/decks/019de076-2351-76a2-9dc5-1c75bf1dd158",
      "deckAnchorHref": "/decks/019de076-2351-76a2-9dc5-1c75bf1dd158#slide-23",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-2351-76a2-9dc5-1c75bf1dd158",
      "docSlug": "905d9ceaf5cb608feb86b583a8401e54",
      "documentTitle": "AstraZeneca | Results Presentation Deck | 45 slides",
      "authorId": "astrazeneca",
      "authorName": "AstraZeneca",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 24,
      "slideType": "key_messages",
      "function": "present_solution",
      "notes": "Uses a custom matrix-like layout to show drug combinations and monotherapies against disease prevalence segments.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-2351-76a2-9dc5-1c75bf1dd158/24",
      "deckHref": "/decks/019de076-2351-76a2-9dc5-1c75bf1dd158",
      "deckAnchorHref": "/decks/019de076-2351-76a2-9dc5-1c75bf1dd158#slide-24",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-2351-76a2-9dc5-1c75bf1dd158",
      "docSlug": "905d9ceaf5cb608feb86b583a8401e54",
      "documentTitle": "AstraZeneca | Results Presentation Deck | 45 slides",
      "authorId": "astrazeneca",
      "authorName": "AstraZeneca",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 25,
      "slideType": "key_takeaways",
      "function": "analyze_data",
      "notes": "Includes a bar chart for UACR reduction and a mechanism-of-action/pipeline diagram for tozorakimab.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-2351-76a2-9dc5-1c75bf1dd158/25",
      "deckHref": "/decks/019de076-2351-76a2-9dc5-1c75bf1dd158",
      "deckAnchorHref": "/decks/019de076-2351-76a2-9dc5-1c75bf1dd158#slide-25",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-2351-76a2-9dc5-1c75bf1dd158",
      "docSlug": "905d9ceaf5cb608feb86b583a8401e54",
      "documentTitle": "AstraZeneca | Results Presentation Deck | 45 slides",
      "authorId": "astrazeneca",
      "authorName": "AstraZeneca",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 26,
      "slideType": "thesis_headline",
      "function": "size_opportunity",
      "notes": "Includes a navigation bar at the top indicating the current section is 'BioPharmaceuticals'.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-2351-76a2-9dc5-1c75bf1dd158/26",
      "deckHref": "/decks/019de076-2351-76a2-9dc5-1c75bf1dd158",
      "deckAnchorHref": "/decks/019de076-2351-76a2-9dc5-1c75bf1dd158#slide-26",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-2351-76a2-9dc5-1c75bf1dd158",
      "docSlug": "905d9ceaf5cb608feb86b583a8401e54",
      "documentTitle": "AstraZeneca | Results Presentation Deck | 45 slides",
      "authorId": "astrazeneca",
      "authorName": "AstraZeneca",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 27,
      "slideType": "cover",
      "function": "front_matter",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-2351-76a2-9dc5-1c75bf1dd158/27",
      "deckHref": "/decks/019de076-2351-76a2-9dc5-1c75bf1dd158",
      "deckAnchorHref": "/decks/019de076-2351-76a2-9dc5-1c75bf1dd158#slide-27",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-2351-76a2-9dc5-1c75bf1dd158",
      "docSlug": "905d9ceaf5cb608feb86b583a8401e54",
      "documentTitle": "AstraZeneca | Results Presentation Deck | 45 slides",
      "authorId": "astrazeneca",
      "authorName": "AstraZeneca",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 28,
      "slideType": "kpi_overview",
      "function": "analyze_data",
      "notes": "Includes revenue breakdown for Ultomiris, Soliris, Strensiq, and others; regional breakdown; and C5 franchise indication mix.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-2351-76a2-9dc5-1c75bf1dd158/28",
      "deckHref": "/decks/019de076-2351-76a2-9dc5-1c75bf1dd158",
      "deckAnchorHref": "/decks/019de076-2351-76a2-9dc5-1c75bf1dd158#slide-28",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-2351-76a2-9dc5-1c75bf1dd158",
      "docSlug": "905d9ceaf5cb608feb86b583a8401e54",
      "documentTitle": "AstraZeneca | Results Presentation Deck | 45 slides",
      "authorId": "astrazeneca",
      "authorName": "AstraZeneca",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 29,
      "slideType": "key_takeaways",
      "function": "summarize",
      "notes": "Includes clinical trial data visualization and market sizing for IgAN.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-2351-76a2-9dc5-1c75bf1dd158/29",
      "deckHref": "/decks/019de076-2351-76a2-9dc5-1c75bf1dd158",
      "deckAnchorHref": "/decks/019de076-2351-76a2-9dc5-1c75bf1dd158#slide-29",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-2351-76a2-9dc5-1c75bf1dd158",
      "docSlug": "905d9ceaf5cb608feb86b583a8401e54",
      "documentTitle": "AstraZeneca | Results Presentation Deck | 45 slides",
      "authorId": "astrazeneca",
      "authorName": "AstraZeneca",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 30,
      "slideType": "closing_ask",
      "function": "summarize",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-2351-76a2-9dc5-1c75bf1dd158/30",
      "deckHref": "/decks/019de076-2351-76a2-9dc5-1c75bf1dd158",
      "deckAnchorHref": "/decks/019de076-2351-76a2-9dc5-1c75bf1dd158#slide-30",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 32,
          "from": 30,
          "beatId": "e091dced-3d80-400a-9573-9287f2104020",
          "arcName": "Monroe's Motivated Sequence",
          "arcSlug": "monroes-sequence",
          "beatName": "Action",
          "beatSlug": "monroes-sequence-action",
          "evidence": "CEO closing remarks and Q&A session",
          "position": 3,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-2351-76a2-9dc5-1c75bf1dd158",
      "docSlug": "905d9ceaf5cb608feb86b583a8401e54",
      "documentTitle": "AstraZeneca | Results Presentation Deck | 45 slides",
      "authorId": "astrazeneca",
      "authorName": "AstraZeneca",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 31,
      "slideType": "key_messages",
      "function": "summarize",
      "notes": "The slide uses a navigation bar at the top to indicate the current section is 'CEO Opening Remarks'.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-2351-76a2-9dc5-1c75bf1dd158/31",
      "deckHref": "/decks/019de076-2351-76a2-9dc5-1c75bf1dd158",
      "deckAnchorHref": "/decks/019de076-2351-76a2-9dc5-1c75bf1dd158#slide-31",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 32,
          "from": 30,
          "beatId": "e091dced-3d80-400a-9573-9287f2104020",
          "arcName": "Monroe's Motivated Sequence",
          "arcSlug": "monroes-sequence",
          "beatName": "Action",
          "beatSlug": "monroes-sequence-action",
          "evidence": "CEO closing remarks and Q&A session",
          "position": 3,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-2351-76a2-9dc5-1c75bf1dd158",
      "docSlug": "905d9ceaf5cb608feb86b583a8401e54",
      "documentTitle": "AstraZeneca | Results Presentation Deck | 45 slides",
      "authorId": "astrazeneca",
      "authorName": "AstraZeneca",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 32,
      "slideType": "other",
      "function": "other",
      "notes": "Slide 32 of a presentation, likely AstraZeneca given the executives listed.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-2351-76a2-9dc5-1c75bf1dd158/32",
      "deckHref": "/decks/019de076-2351-76a2-9dc5-1c75bf1dd158",
      "deckAnchorHref": "/decks/019de076-2351-76a2-9dc5-1c75bf1dd158#slide-32",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 32,
          "from": 30,
          "beatId": "e091dced-3d80-400a-9573-9287f2104020",
          "arcName": "Monroe's Motivated Sequence",
          "arcSlug": "monroes-sequence",
          "beatName": "Action",
          "beatSlug": "monroes-sequence-action",
          "evidence": "CEO closing remarks and Q&A session",
          "position": 3,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-2351-76a2-9dc5-1c75bf1dd158",
      "docSlug": "905d9ceaf5cb608feb86b583a8401e54",
      "documentTitle": "AstraZeneca | Results Presentation Deck | 45 slides",
      "authorId": "astrazeneca",
      "authorName": "AstraZeneca",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 33,
      "slideType": "appendix",
      "function": "appendix",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-2351-76a2-9dc5-1c75bf1dd158/33",
      "deckHref": "/decks/019de076-2351-76a2-9dc5-1c75bf1dd158",
      "deckAnchorHref": "/decks/019de076-2351-76a2-9dc5-1c75bf1dd158#slide-33",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-2351-76a2-9dc5-1c75bf1dd158",
      "docSlug": "905d9ceaf5cb608feb86b583a8401e54",
      "documentTitle": "AstraZeneca | Results Presentation Deck | 45 slides",
      "authorId": "astrazeneca",
      "authorName": "AstraZeneca",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 34,
      "slideType": "appendix_data",
      "function": "summarize",
      "notes": "The slide uses color coding to distinguish between therapeutic areas: Oncology (dark purple), BioPharmaceuticals (light blue), and Rare Disease (magenta).",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-2351-76a2-9dc5-1c75bf1dd158/34",
      "deckHref": "/decks/019de076-2351-76a2-9dc5-1c75bf1dd158",
      "deckAnchorHref": "/decks/019de076-2351-76a2-9dc5-1c75bf1dd158#slide-34",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-2351-76a2-9dc5-1c75bf1dd158",
      "docSlug": "905d9ceaf5cb608feb86b583a8401e54",
      "documentTitle": "AstraZeneca | Results Presentation Deck | 45 slides",
      "authorId": "astrazeneca",
      "authorName": "AstraZeneca",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 35,
      "slideType": "appendix_data",
      "function": "analyze_data",
      "notes": "The matrix uses color-coding and shading to distinguish between different drug classes and established standards of care.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-2351-76a2-9dc5-1c75bf1dd158/35",
      "deckHref": "/decks/019de076-2351-76a2-9dc5-1c75bf1dd158",
      "deckAnchorHref": "/decks/019de076-2351-76a2-9dc5-1c75bf1dd158#slide-35",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-2351-76a2-9dc5-1c75bf1dd158",
      "docSlug": "905d9ceaf5cb608feb86b583a8401e54",
      "documentTitle": "AstraZeneca | Results Presentation Deck | 45 slides",
      "authorId": "astrazeneca",
      "authorName": "AstraZeneca",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 36,
      "slideType": "appendix_data",
      "function": "analyze_data",
      "notes": "The slide uses a grid layout to categorize clinical trials by patient population and treatment line, with shading indicating established standard of care (SoC).",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-2351-76a2-9dc5-1c75bf1dd158/36",
      "deckHref": "/decks/019de076-2351-76a2-9dc5-1c75bf1dd158",
      "deckAnchorHref": "/decks/019de076-2351-76a2-9dc5-1c75bf1dd158#slide-36",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-2351-76a2-9dc5-1c75bf1dd158",
      "docSlug": "905d9ceaf5cb608feb86b583a8401e54",
      "documentTitle": "AstraZeneca | Results Presentation Deck | 45 slides",
      "authorId": "astrazeneca",
      "authorName": "AstraZeneca",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 37,
      "slideType": "appendix_data",
      "function": "analyze_data",
      "notes": "The slide uses a matrix-like structure to map patient risk profiles against treatment lines, highlighting specific drug trials (e.g., SERENA, CAPItello, CAMBRIA, DESTINY).",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-2351-76a2-9dc5-1c75bf1dd158/37",
      "deckHref": "/decks/019de076-2351-76a2-9dc5-1c75bf1dd158",
      "deckAnchorHref": "/decks/019de076-2351-76a2-9dc5-1c75bf1dd158#slide-37",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-2351-76a2-9dc5-1c75bf1dd158",
      "docSlug": "905d9ceaf5cb608feb86b583a8401e54",
      "documentTitle": "AstraZeneca | Results Presentation Deck | 45 slides",
      "authorId": "astrazeneca",
      "authorName": "AstraZeneca",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 38,
      "slideType": "appendix_data",
      "function": "analyze_data",
      "notes": "The chart tracks revenue performance across three categories over nine quarters.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-2351-76a2-9dc5-1c75bf1dd158/38",
      "deckHref": "/decks/019de076-2351-76a2-9dc5-1c75bf1dd158",
      "deckAnchorHref": "/decks/019de076-2351-76a2-9dc5-1c75bf1dd158#slide-38",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-2351-76a2-9dc5-1c75bf1dd158",
      "docSlug": "905d9ceaf5cb608feb86b583a8401e54",
      "documentTitle": "AstraZeneca | Results Presentation Deck | 45 slides",
      "authorId": "astrazeneca",
      "authorName": "AstraZeneca",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 39,
      "slideType": "appendix_data",
      "function": "analyze_data",
      "notes": "Data presented in stacked bar charts with corresponding data tables below each chart.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-2351-76a2-9dc5-1c75bf1dd158/39",
      "deckHref": "/decks/019de076-2351-76a2-9dc5-1c75bf1dd158",
      "deckAnchorHref": "/decks/019de076-2351-76a2-9dc5-1c75bf1dd158#slide-39",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-2351-76a2-9dc5-1c75bf1dd158",
      "docSlug": "905d9ceaf5cb608feb86b583a8401e54",
      "documentTitle": "AstraZeneca | Results Presentation Deck | 45 slides",
      "authorId": "astrazeneca",
      "authorName": "AstraZeneca",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 40,
      "slideType": "appendix_data",
      "function": "analyze_data",
      "notes": "Contains two charts: a stacked bar chart for product sales and a grouped bar chart for collaboration revenue.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-2351-76a2-9dc5-1c75bf1dd158/40",
      "deckHref": "/decks/019de076-2351-76a2-9dc5-1c75bf1dd158",
      "deckAnchorHref": "/decks/019de076-2351-76a2-9dc5-1c75bf1dd158#slide-40",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-2351-76a2-9dc5-1c75bf1dd158",
      "docSlug": "905d9ceaf5cb608feb86b583a8401e54",
      "documentTitle": "AstraZeneca | Results Presentation Deck | 45 slides",
      "authorId": "astrazeneca",
      "authorName": "AstraZeneca",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 41,
      "slideType": "appendix_data",
      "function": "analyze_data",
      "notes": "Data presented in stacked bar charts with corresponding data tables below each chart.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-2351-76a2-9dc5-1c75bf1dd158/41",
      "deckHref": "/decks/019de076-2351-76a2-9dc5-1c75bf1dd158",
      "deckAnchorHref": "/decks/019de076-2351-76a2-9dc5-1c75bf1dd158#slide-41",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-2351-76a2-9dc5-1c75bf1dd158",
      "docSlug": "905d9ceaf5cb608feb86b583a8401e54",
      "documentTitle": "AstraZeneca | Results Presentation Deck | 45 slides",
      "authorId": "astrazeneca",
      "authorName": "AstraZeneca",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 42,
      "slideType": "appendix_data",
      "function": "analyze_data",
      "notes": "CER = constant exchange rates; EM = Emerging Markets; ERoW = Established Rest of World.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-2351-76a2-9dc5-1c75bf1dd158/42",
      "deckHref": "/decks/019de076-2351-76a2-9dc5-1c75bf1dd158",
      "deckAnchorHref": "/decks/019de076-2351-76a2-9dc5-1c75bf1dd158#slide-42",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-2351-76a2-9dc5-1c75bf1dd158",
      "docSlug": "905d9ceaf5cb608feb86b583a8401e54",
      "documentTitle": "AstraZeneca | Results Presentation Deck | 45 slides",
      "authorId": "astrazeneca",
      "authorName": "AstraZeneca",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 43,
      "slideType": "appendix_data",
      "function": "analyze_data",
      "notes": "Data presented as stacked bar charts with corresponding data tables below each chart.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-2351-76a2-9dc5-1c75bf1dd158/43",
      "deckHref": "/decks/019de076-2351-76a2-9dc5-1c75bf1dd158",
      "deckAnchorHref": "/decks/019de076-2351-76a2-9dc5-1c75bf1dd158#slide-43",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-2351-76a2-9dc5-1c75bf1dd158",
      "docSlug": "905d9ceaf5cb608feb86b583a8401e54",
      "documentTitle": "AstraZeneca | Results Presentation Deck | 45 slides",
      "authorId": "astrazeneca",
      "authorName": "AstraZeneca",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 44,
      "slideType": "appendix_data",
      "function": "analyze_data",
      "notes": "Data presented in stacked bar charts with corresponding data tables below each chart.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-2351-76a2-9dc5-1c75bf1dd158/44",
      "deckHref": "/decks/019de076-2351-76a2-9dc5-1c75bf1dd158",
      "deckAnchorHref": "/decks/019de076-2351-76a2-9dc5-1c75bf1dd158#slide-44",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de076-2351-76a2-9dc5-1c75bf1dd158",
      "docSlug": "905d9ceaf5cb608feb86b583a8401e54",
      "documentTitle": "AstraZeneca | Results Presentation Deck | 45 slides",
      "authorId": "astrazeneca",
      "authorName": "AstraZeneca",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2023-11-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 45,
      "slideType": "appendix_data",
      "function": "analyze_data",
      "notes": "Data presented in stacked bar charts with corresponding data tables below each chart.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de076-2351-76a2-9dc5-1c75bf1dd158/45",
      "deckHref": "/decks/019de076-2351-76a2-9dc5-1c75bf1dd158",
      "deckAnchorHref": "/decks/019de076-2351-76a2-9dc5-1c75bf1dd158#slide-45",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    }
  ]
}